Purespring

Home - Purespring Therapeutics

London, United Kingdom · Founded 2020 · $165.0M raised

Headquarters
London
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$165.0M
Last Round
$105.0M Series BOct 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Purespring Therapeutics is a clinical-stage biotechnology company pioneering gene therapy delivery for kidney diseases, with a proprietary adeno-associated viral (AAV) platform that targets podocytes — specialized kidney cells implicated in approximately 60% of renal diseases. Founded in 2020 and headquartered in London, the company is developing precisely targeted, low-dose therapies for conditions such as IgA nephropathy (IgAN) that aim to prevent renal failure and eliminate the need for dialysis or transplantation. Purespring is the first company to successfully treat kidney disease models by directly targeting the podocyte via AAV gene therapy. The company has raised over $165 million across two funding rounds backed by leading life science investors.

Summary

Purespring is a Biotech company based in London, United Kingdom, founded in 2020. It has raised $165.0M in total across 2 rounds, most recently a $105.0M Series B round in Oct 2024. Investors include Syncona Partners, Sofinnova Partners and Gilde Healthcare.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2024
$105.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Purespring on Indexed.vc
<a href="https://indexed.vc/companies/purespring"><img src="https://indexed.vc/api/badge/company/purespring" alt="Purespring on Indexed.vc" width="260" height="76" /></a>